Show simple item record

dc.contributor.authorPareek, M
dc.contributor.authorGreenaway, C
dc.contributor.authorNoori, T
dc.contributor.authorMunoz, J
dc.contributor.authorZenner, D
dc.date.accessioned2020-12-03T11:03:36Z
dc.date.available2016-03-08
dc.date.available2020-12-03T11:03:36Z
dc.date.issued2016-03-23
dc.identifier.citationPareek, M., Greenaway, C., Noori, T. et al. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med 14, 48 (2016). https://doi.org/10.1186/s12916-016-0595-5en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/68980
dc.description.abstractTuberculosis (TB) causes significant morbidity and mortality in high-income countries with foreign-born individuals bearing a disproportionate burden of the overall TB case burden in these countries. In this review of tuberculosis and migration we discuss the impact of migration on the epidemiology of TB in low burden countries, describe the various screening strategies to address this issue, review the yield and cost-effectiveness of these programs and describe the gaps in knowledge as well as possible future solutions.The reasons for the TB burden in the migrant population are likely to be the reactivation of remotely-acquired latent tuberculosis infection (LTBI) following migration from low/intermediate-income high TB burden settings to high-income, low TB burden countries.TB control in high-income countries has historically focused on the early identification and treatment of active TB with accompanying contact-tracing. In the face of the TB case-load in migrant populations, however, there is ongoing discussion about how best to identify TB in migrant populations. In general, countries have generally focused on two methods: identification of active TB (either at/post-arrival or increasingly pre-arrival in countries of origin) and secondly, conditionally supported by WHO guidance, through identifying LTBI in migrants from high TB burden countries. Although health-economic analyses have shown that TB control in high income settings would benefit from providing targeted LTBI screening and treatment to certain migrants from high TB burden countries, implementation issues and barriers such as sub-optimal treatment completion will need to be addressed to ensure program efficacy.en_US
dc.languageeng
dc.relation.ispartofBMC Medicine
dc.rightsCreative Commons Attribution 4.0 International License
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMigrationen_US
dc.subjectReviewen_US
dc.subjectScreeningen_US
dc.subjectTuberculosisen_US
dc.subjectCommunicable Disease Controlen_US
dc.subjectDeveloped Countriesen_US
dc.subjectEmigration and Immigrationen_US
dc.subjectHumansen_US
dc.subjectIncomeen_US
dc.subjectRisk Factorsen_US
dc.subjectTravelen_US
dc.subjectTuberculosisen_US
dc.subjectTuberculosis, Multidrug-Resistanten_US
dc.titleThe impact of migration on tuberculosis epidemiology and control in high-income countries: a review.en_US
dc.typeArticleen_US
dc.rights.holder© 2016 Pareek et al.
dc.identifier.doi10.1186/s12916-016-0595-5
dc.identifier.doihttps://doi.org/10.1186/s12916-016-0595-5
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/27004556en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume14en_US
dcterms.dateAccepted2016-03-08
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International License
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International License